Strata Critical Medical, Inc.

SRTA • Medical - Care Facilities

$4.69

— 0.00 (0.00%)

ResultadosÚltimo reporte: 30 jun 2026

PERFIL EQUILIBRADONeutralConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Perfil mixto. La empresa no es necesariamente mala, pero la valoración, el crecimiento o el balance todavía no justifican una señal más fuerte.

Capitalización

$404.34M

Crecimiento

-9.1%

Flujo de caja

0/5

Tendencia

Negative

Evidencia

Crecimiento positivo de ingresos · 35.0%Nivel de deuda manejable · 0.01Liquidez saludable · 6.38Rentabilidad débil

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 6 ago 2026, 1:11 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$4.69

Change0.00%

Shares Out86.21M

Market Cap$404.34M

Enterprise Value$385.85M

52W Range3.67 - 6.50

Beta2.22

P/E9.19

P/S1.58

P/B1.45

P/FCF-9.22

EV/Sales1.51

Price$4.69

Change0.00%

Shares Out86.21M

Market Cap$404.34M

Enterprise Value$385.85M

52W Range3.67 - 6.50

Beta2.22

P/E9.19

P/S1.58

P/B1.45

P/FCF-9.22

EV/Sales1.51

EV/EBITDA-49.35

EV/FCF-8.80

Earnings Yield10.88%

FCF Yield-10.84%

Dividend Yield0.00%

Gross Margin19.44%

Oper. Margin-4.97%

Profit Margin-7.94%

Debt/Eq0.01

Current Ratio6.38

Quick Ratio6.38

Revenue 5Y-9.10%

Target$7.25

Target Upside54.58%

Target Median$7.25

Target Range7.25 - 7.25

Volume2.48M

Avg Volume1.11M

EPS Surprise0.07

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

22/100

Fortaleza financiera

Deuda, caja, estabilidad

76/100

Potencial de crecimiento

Ingresos y expansión

95/100

Atractivo del precio

Barata o cara hoy

89/100

Por qué este puntaje▼

Crecimiento positivo de ingresos · 35.0%Nivel de deuda manejable · 0.01Liquidez saludable · 6.38Rentabilidad débil

Analyst view

Analyst sentiment and price target

SRTA

Analyst sentiment

Based on 6 analyst votes · 2026-10-20

100/100

Bullish

Hold

Bearish

Precio objetivo

2026-08-06

Bajo

$7.25

Promedio

$7.25

Mediana

$7.25

Alto

$7.25

Resumen de la compañía

IPO: 11/5/2019

Industria: Medical - Care Facilities

P/B i: 1.45

Deuda / Patrimonio i: 0.01

Margen operativo: -4.97%

Margen neto: -7.94%

ROE i: -

ROIC: -

Salud financiera

Puntaje15 / 20

Deuda / Patrimonio: 0.01

Ratio corriente: 6.38

Ratio rápido: 6.38

Estado: Good

Transacciones internas

Actividad reciente de ejecutivos e insiders

⚠ 2 venta interna de alto volumens detectadas

Cohen Amir

Transacción: 07/31/2026

VENTA

Cambio

-34,015

Precio

$5.09

Presentación

08/03/2026

Tipo

VENTA

Tomkiel Melissa M.

Transacción: 07/31/2026

VENTA

Cambio

-212,309

Precio

$5.09

Presentación

08/03/2026

Tipo

VENTA

Heyburn William A.

Transacción: 07/31/2026

VENTA

Cambio

-199,209

Precio

$5.09

Presentación

08/03/2026

Tipo

VENTA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
Cohen Amir	VENTA	-34,015	$5.09	07/31/2026	08/03/2026
Tomkiel Melissa M.	VENTA	-212,309	$5.09	07/31/2026	08/03/2026
Heyburn William A.	VENTA	-199,209	$5.09	07/31/2026	08/03/2026
Wunsch Scott M	VENTA	-13,992	$5.09	07/31/2026	08/03/2026
Cohen Amir	COMPRA	+41,786	Not reported	07/30/2026	08/03/2026
Tomkiel Melissa M.	COMPRA	+208,929	Not reported	07/30/2026	08/03/2026
Heyburn William A.	COMPRA	+181,071	Not reported	07/30/2026	08/03/2026
Wunsch Scott M	COMPRA	+57,172	Not reported	07/30/2026	08/03/2026
LAUCK ANDREW	COMPRA	+35,260	Not reported	07/30/2026	08/03/2026
WIESENTHAL ROBERT S	COMPRA	+50,234	Not reported	07/30/2026	08/03/2026
PHILIP EDWARD M	COMPRA	+30,913	Not reported	07/30/2026	08/03/2026
Love Reginald	COMPRA	+37,675	Not reported	07/30/2026	08/03/2026
Cook William L. III	COMPRA	+44,438	Not reported	07/30/2026	08/03/2026
Wunsch Scott M	VENTA	-5,550	$5.87	06/08/2026	06/18/2026
Tomkiel Melissa M.	VENTA	-29,730	$5.87	06/08/2026	06/18/2026
Cohen Amir	VENTA	-4,655	$5.87	06/08/2026	06/18/2026
Heyburn William A.	VENTA	-31,671	$5.87	06/08/2026	06/18/2026
Wunsch Scott M	VENTA	-5,550	$5.87	06/08/2026	06/10/2026
Tomkiel Melissa M.	VENTA	-29,730	$5.87	06/08/2026	06/10/2026
Cohen Amir	VENTA	-4,655	$5.87	06/08/2026	06/10/2026

Sobre la compañía

Strata Critical Medical, Inc.

Strata Critical Medical, Inc. is dedicated to supporting healthcare providers throughout the United States by offering swift logistical management and specialized medical assistance. A significant part of their operations involves the movement of human organs for transplant, utilizing both aerial and ground transportation methods. Founded in 2014, the organization previously operated under the name Blade Air Mobility, Inc. and is set to officially change its name to Strata Critical Medical, Inc. in August of 2025. Its primary corporate office is located in New York, New York.

Fuente - Link

Competidores

AIRO CYRX EBF EVTL FLYX KFRC MTRX ORN ULH ZIP

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Strata Critical to Present at the 2026 Jefferies Healthcare Services and Technology Conference

NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that management will present at the 2026 Jefferies Healthcare Services and Technology Conference on Monday, September 14, 2026, at 2:15 pm ET. A webcast of the event will be available at the link here. A replay will be available shortly after the conclusion of the presentation on the investor relations section of the Company's website at https://ir.stratacritical.com/.

GlobeNewsWire

Strata Critical Medical, Inc. (SRTA) Upgraded to Buy: What Does It Mean for the Stock?

Strata Critical Medical, Inc. (SRTA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research

Does Strata Critical Medical, Inc. (SRTA) Have the Potential to Rally 47.28% as Wall Street Analysts Expect?

The mean of analysts' price targets for Strata Critical Medical, Inc. (SRTA) points to a 47.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Investment Research

Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates?

Strata Critical Medical, Inc. (SRTA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Investment Research

Wall Street Analysts Predict a 60% Upside in Strata Critical Medical, Inc. (SRTA): Here's What You Should Know

The consensus price target hints at a 60% upside potential for Strata Critical Medical, Inc. (SRTA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks Investment Research

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-05-06	-0.04	0.03	0.07
2026-03-03	0.01	-0.06214	-0.07214
2025-11-10	-0.02	-0.06	-0.04
2025-08-05	-0.04	-0.05	-0.01
2025-05-12	-0.11	-0.04	0.07
2025-03-13	-0.12	-0.12	0
2024-11-12	-0.06	-0.03	0.03
2024-08-07	-0.06	-0.06	0
2024-05-07	-0.13	-0.06	0.07
2024-03-12	-0.13	-0.23	-0.1
2023-11-08	-0.1	0.00357	0.10357
2023-08-09	-0.14	-0.11	0.03